DBS is fighting a S$1.3 billion 1MDB lawsuit, but the bank says no provision needed. Meanwhile, Mapletree Logistics Trust just locked yuan debt at 2.1 per cent, Sembcorp walked away from a S$105 million solar deal, and Kore US REIT refinanced two-thirds of its 2027 debt wall. None moved the share price. I break down which headline you should actually care about, and why litigation noise keeps distracting you from real financing risk.
Key takeaways:
DBS categorically rejects the claim, says no balance sheet impact yet
Mapletree’s dim sum bond at 2.1 per cent is real cost savings, if unhedged
Sembcorp exits Philippine deal, shares flat at 0.3 per cent move
Kore US REIT covers 65 per cent of 2027 maturities, over a year early
Market reaction tells you more than the headline number
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
